Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions
OBJECTIVES: To document and characterize freezing temperatures in the Indonesian vaccine cold chain and to evaluate the feasibility of changes designed to reduce the occurrence of freezing. METHODS: Data loggers were used to measure temperatures of shipments of hepatitis B vaccine from manufacturer...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
The World Health Organization,
2004-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_847b2a1a95b24241a943abd0081a3910 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Nelson Carib M. |e author |
700 | 1 | 0 | |a Wibisono Hariadi |e author |
700 | 1 | 0 | |a Purwanto Hary |e author |
700 | 1 | 0 | |a Mansyur Isa |e author |
700 | 1 | 0 | |a Moniaga Vanda |e author |
700 | 1 | 0 | |a Widjaya Anton |e author |
245 | 0 | 0 | |a Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions |
260 | |b The World Health Organization, |c 2004-01-01T00:00:00Z. | ||
500 | |a 0042-9686 | ||
520 | |a OBJECTIVES: To document and characterize freezing temperatures in the Indonesian vaccine cold chain and to evaluate the feasibility of changes designed to reduce the occurrence of freezing. METHODS: Data loggers were used to measure temperatures of shipments of hepatitis B vaccine from manufacturer to point of use. Baseline conditions and three intervention phases were monitored. During each of the intervention phases, vaccines were removed progressively from the standard 2-8 °C cold chain. FINDINGS: Freezing temperatures were recorded in 75% of baseline shipments. The highest rates of freezing occurred during transport from province to district, storage in district-level ice-lined refrigerators, and storage in refrigerators in health centres. Interventions reduced freezing, without excessive heat exposure. CONCLUSIONS: Inadvertent freezing of freeze-sensitive vaccines is widespread in Indonesia. Simple strategies exist to reduce freezing - for example, selective transport and storage of vaccines at ambient temperatures. The use of vaccine vial monitors reduces the risk associated with heat-damaged vaccines in these scenarios. Policy changes that allow limited storage of freeze-sensitive vaccines at temperatures >2-8 °C would enable flexible vaccine distribution strategies that could reduce vaccine freezing, reduce costs, and increase capacity. | ||
546 | |a EN | ||
690 | |a Hepatitis B vaccines | ||
690 | |a Freezing | ||
690 | |a Refrigeration | ||
690 | |a Drug storage/methods | ||
690 | |a Transportation | ||
690 | |a Drug stability | ||
690 | |a Child health services | ||
690 | |a Indonesia | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Bulletin of the World Health Organization, Vol 82, Iss 2, Pp 99-105 (2004) | |
787 | 0 | |n http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000200006 | |
787 | 0 | |n https://doaj.org/toc/0042-9686 | |
856 | 4 | 1 | |u https://doaj.org/article/847b2a1a95b24241a943abd0081a3910 |z Connect to this object online. |